Molecular Epidemiology of Carbapenem-Resistant Klebsiella Pneumoniae in Greece

References

• Tanwar J, Das S, Fatima Z, Hameed S. Multidrug resistance: an emerging crisis. Interdiscip. Perspect. Infect. Dis. 2014, 541340 (2014).
   PubMedGoogle Scholar
• WHO. Prevention of Hospital-Acquired Infections. A Practical Guide (2nd Edition). Ducel G, Fabry J, Nicolle L( Eds ) . WHO, Malta, 4 – 5 (2002).
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18 (3 ), 268 – 281 (2012).
   PubMed Web of Science ®Google Scholar
• Mischnik A, Kaase M, Lubbert C, Seifert H, Kern WV. Carbapenem-resistance in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii. Dtsch Med. Wochenschr. 140 (3 ), 172 – 176 (2015).
   PubMed Web of Science ®Google Scholar
• HCDCP. Action plan for the management of infections by multidrug-resistant Gram negative pathogens in health care facilities. Procrustes 2 – 3 (2010).
   Google Scholar
• Hall BG, Barlow M. Revised Ambler classification of (beta)-lactamases. J. Antimicrob. Chemother. 55 (6 ), 1050 – 1051 (2005).
   PubMed Web of Science ®Google Scholar
• Zeng ZR, Wang WP, Huang M, Shi LN, Wang Y, Shao HF. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China. Diagn. Microbiol. Infect. Dis. 78 (3 ), 268 – 270 (2014).
   PubMed Web of Science ®Google Scholar
• Li XZ, Plesiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28 (2 ), 337 – 418 (2015).
   PubMed Web of Science ®Google Scholar
• Moya B, Beceiro A, Cabot G et al. Pan-beta-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities. Antimicrob. Agents Chemother. 56 (9 ), 4771 – 4778 (2012).
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39 (6 ), 1211 – 1233 (1995).
   PubMed Web of Science ®Google Scholar
• Akinci E, Vahaboglu H. Minor extended-spectrum beta-lactamases. Expert Rev. Anti. Infect. Ther. 8 (11 ), 1251 – 1258 (2010).
   PubMed Web of Science ®Google Scholar
• El Salabi A, Borra PS, Toleman MA, Samuelsen O, Walsh TR. Genetic and biochemical characterization of a novel metallo-beta-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob. Agents Chemother. 56 (5 ), 2241 – 2245 (2012).
   PubMed Web of Science ®Google Scholar
• Marsik FJ, Nambiar S. Review of carbapenemases and AmpC-beta lactamases. Pediatr. Infect. Dis. J. 30 (12 ), 1094 – 1095 (2011).
   PubMed Web of Science ®Google Scholar
• Antunes NT, Lamoureaux TL, Toth M, Stewart NK, Frase H, Vakulenko SB. Class D beta-lactamases: are they all carbapenemases? Antimicrob. Agents Chemother. 58 (4 ), 2119 – 2125 (2014).
   PubMed Web of Science ®Google Scholar
• San Millan A, Toll-Riera M, Escudero JA, Canton R, Coque TM, Maclean RC. Sequencing of plasmids pAMBL1 and pAMBL2 from Pseudomonas aeruginosa reveals a blaVIM-1 amplification causing high-level carbapenem resistance. J. Antimicrob. Chemother. 70 (11 ), 3000 – 3003 (2015).
   PubMed Web of Science ®Google Scholar
• Giakkoupi P, Xanthaki A, Kanelopoulou M et al. VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J. Clin. Microbiol. 41 (8 ), 3893 – 3896 (2003).
   PubMed Web of Science ®Google Scholar
• Senda K, Arakawa Y, Ichiyama S et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J. Clin. Microbiol. 34 (12 ), 2909 – 2913 (1996).
   PubMed Web of Science ®Google Scholar
• Osano E, Arakawa Y, Wacharotayankun R et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38 (1 ), 71 – 78 (1994).
   PubMed Web of Science ®Google Scholar
• Koh TH, Sng LH, Babini GS, Woodford N, Livermore DM, Hall LM. Carbapenem-resistant Klebsiella pnuemoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein. Antimicrob. Agents Chemother. 45 (6 ), 1939 – 1940 (2001).
   PubMed Web of Science ®Google Scholar
• Yan JJ, Ko WC, Tsai SH, Wu HM, Wu JJ. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a University Medical Center in Taiwan. J. Clin. Microbiol. 39 (12 ), 4433 – 4439 (2001).
   PubMed Web of Science ®Google Scholar
• Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17 (10 ), 1791 – 1798 (2011).
   PubMed Web of Science ®Google Scholar
• Limbago BM, Rasheed JK, Anderson KF et al. IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J. Clin. Microbiol. 49 (12 ), 4239 – 4245 (2011).
   PubMed Web of Science ®Google Scholar
• Li B, Xu XH, Zhao ZC, Wang MH, Cao YP. High prevalence of metallo-beta-lactamase among carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China. Can. J. Microbiol. 60 (10 ), 691 – 695 (2014).
   PubMed Web of Science ®Google Scholar
• Jian Z, Li Y, Liu W et al. Detection of the novel IMP-38 among carbapenemase-producing Enterobacteriaceae in a University Hospital, China. J. Infect. Dev. Ctries 8 (8 ), 1044 – 1048 (2014).
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44 (4 ), 891 – 897 (2000).
   PubMed Web of Science ®Google Scholar
• Lauretti L, Riccio ML, Mazzariol A et al. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43 (7 ), 1584 – 1590 (1999).
   PubMed Web of Science ®Google Scholar
• Miriagou V, Tzelepi E, Gianneli D, Tzouvelekis LS. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1. Antimicrob. Agents Chemother. 47 (1 ), 395 – 397 (2003).
   PubMed Web of Science ®Google Scholar
• Ikonomidis A, Tokatlidou D, Kristo I et al. Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-(beta)-lactamase gene. J. Clin. Microbiol. 43 (10 ), 5344 – 5347 (2005).
   PubMed Web of Science ®Google Scholar
• Zagorianou A, Sianou E, Iosifidis E et al. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004–2010. Euro. Surveill. 17 (7 ), pii: 20088 (2012).
   Google Scholar
• Pournaras S, Ikonomidis A, Tzouvelekis LS et al. VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid. Antimicrob. Agents Chemother. 49 (12 ), 5153 – 5156 (2005).
   PubMed Web of Science ®Google Scholar
• Sneath PHA, Sokal RR. Numerical Taxonomy. Freeman, CA, USA (1973).
   Google Scholar
• Nei M, Kumar S. Molecular Evolution and Phylogenetics. Oxford University Press, NY, USA (2000).
   Google Scholar
• Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30, 2725 – 2729 (2013).
   PubMed Web of Science ®Google Scholar
• Kassis-Chikhani N, Decre D, Gautier V et al. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French University Hospital. J. Antimicrob. Chemother. 57 (1 ), 142 – 145 (2006).
   PubMed Web of Science ®Google Scholar
• Psichogiou M, Tassios PT, Avlamis A et al. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J. Antimicrob. Chemother. 61 (1 ), 59 – 63 (2008).
   PubMed Web of Science ®Google Scholar
• Hasan CM, Turlej-Rogacka A, Vatopoulos AC, Giakkoupi P, Maatallah M, Giske CG. Dissemination of blaVIM in Greece at the peak of the epidemic of 2005–2006: clonal expansion of Klebsiella pneumoniae clonal complex 147. Clin. Microbiol. Infect. 20 (1 ), 34 – 37 (2013).
   PubMed Web of Science ®Google Scholar
• Papagiannitsis CC, Giakkoupi P, Kotsakis SD et al. OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae. J. Chemother. 25 (4 ), 250 – 254 (2013).
   PubMed Web of Science ®Google Scholar
• Tokatlidou D, Tsivitanidou M, Pournaras S, Ikonomidis A, Tsakris A, Sofianou D. Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a University Hospital. J. Clin. Microbiol. 46 (3 ), 1005 – 1008 (2008).
   PubMed Web of Science ®Google Scholar
• Samuelsen O, Toleman MA, Hasseltvedt V et al. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin. Microbiol. Infect. 17 (12 ), 1811 – 1816 (2011).
   PubMed Web of Science ®Google Scholar
• Pournaras S, Poulou A, Voulgari E, Vrioni G, Kristo I, Tsakris A. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. J. Antimicrob. Chemother. 65 (8 ), 1604 – 1607 (2010).
   PubMed Web of Science ®Google Scholar
• Papagiannitsis CC, Giakkoupi P, Vatopoulos AC, Tryfinopoulou K, Miriagou V, Tzouvelekis LS. Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 beta-lactamases. Int. J. Antimicrob. Agents 36 (6 ), 573 – 574 (2010).
   PubMed Web of Science ®Google Scholar
• Papagiannitsis CC, Miriagou V, Giakkoupi P, Tzouvelekis LS, Vatopoulos AC. Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-beta-lactamase. J. Antimicrob. Chemother. 68 (10 ), 2259 – 2262 (2013).
   PubMed Web of Science ®Google Scholar
• Papagiannitsis CC, Kotsakis SD, Petinaki E et al. Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147. Antimicrob. Agents Chemother. 55 (7 ), 3570 – 3572 (2011).
   PubMed Web of Science ®Google Scholar
• Papagiannitsis CC, Izdebski R, Baraniak A et al. Survey of metallo-beta-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008–11. J. Antimicrob. Chemother. 70 (7 ), 1981 – 1988 (2015).
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53 (12 ), 5046 – 5054 (2009).
   PubMed Web of Science ®Google Scholar
• Moellering RC Jr. NDM-1 – a cause for worldwide concern. N. Engl. J. Med. 363 (25 ), 2377 – 2379 (2010).
   PubMed Web of Science ®Google Scholar
• Voulgari E, Gartzonika C, Vrioni G et al. The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece. J. Antimicrob. Chemother. 69 (8 ), 2091 – 2097 (2014).
   PubMed Web of Science ®Google Scholar
• Spyropoulou A, Bartzavali C, Vamvakopoulou S et al. The first NDM metallo-beta-lactamase producing Klebsiella pneumoniae isolate in a University Hospital of southwestern Greece. J. Chemother. doi: 10.1179/1973947815Y.0000000003 ( 2015 ) ( Epub ahead of print).
   Google Scholar
• Giakkoupi P, Tryfinopoulou K, Kontopidou F et al. Emergence of NDM-producing Klebsiella pneumoniae in Greece. Diagn. Microbiol. Infect. Dis. 77 (4 ), 382 – 384 (2013).
   PubMed Web of Science ®Google Scholar
• Landman D, Bratu S, Kochar S et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother. 60 (1 ), 78 – 82 (2007).
   PubMed Web of Science ®Google Scholar
• Kitchel B, Rasheed JK, Patel JB et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53 (8 ), 3365 – 3370 (2009).
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Giakkoupi P, Maragos A et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J. Infect. 58 (3 ), 213 – 219 (2009).
   PubMed Web of Science ®Google Scholar
• Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J. Antimicrob. Chemother. 62 (6 ), 1257 – 1260 (2008).
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Leavitt A, Schwaber MJ et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother. 53 (2 ), 818 – 820 (2009).
   PubMed Web of Science ®Google Scholar
• Pournaras S, Protonotariou E, Voulgari E et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J. Antimicrob. Chemother. 64 (2 ), 348 – 352 (2009).
   PubMed Web of Science ®Google Scholar
• Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro. Surveill. 14 (21 ), pii:19218 (2009).
   Google Scholar
• Kontopoulou K, Protonotariou E, Vasilakos K et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J. Hosp. Infec.t 76 (1 ), 70 – 73 (2010).
   PubMed Web of Science ®Google Scholar
• Giakkoupi P, Papagiannitsis CC, Miriagou V et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J. Antimicrob. Chemother. 66 (7 ), 1510 – 1513 (2011).
   PubMed Web of Science ®Google Scholar
• Papagiannitsis CC, Miriagou V, Giakkoupi P, Tzouvelekis LS, Vatopoulos AC. Characterization of pKP1433, a novel KPC-2-encoding plasmid from Klebsiella pneumoniae sequence type 340. Antimicrob. Agents Chemother. 57 (7 ), 3427 – 3429 (2013).
   PubMed Web of Science ®Google Scholar
• Tzouvelekis LS, Miriagou V, Kotsakis SD et al. KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen. Antimicrob. Agents Chemother. 57 (10 ), 5144 – 5146 (2013).
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Marangos M, Fligou F et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn. Microbiol. Infect. Dis. 77 (2 ), 169 – 173 (2013).
   PubMed Web of Science ®Google Scholar
• Daikos GL, Tsaousi S, Tzouvelekis LS et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob. Agents Chemother. 58 (4 ), 2322 – 2328 (2014).
   PubMed Web of Science ®Google Scholar
• Schechner V, Kotlovsky T, Kazma M et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin. Microbiol. Infect. 19 (5 ), 451 – 456 (2013).
   PubMed Web of Science ®Google Scholar
• Borer A, Saidel-Odes L, Eskira S et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae. Am J. Infect. Control 40 (5 ), 421 – 425 (2012).
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Spiliopoulou A, Fligou F et al. Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species. Diagn. Microbiol. Infect. Dis. 80 (3 ), 227 – 232 (2014).
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Christofidou M, Fligou F et al. The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients. Infection 42 (5 ), 883 – 890 (2014).
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Bontron S et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemother. 70 (1 ), 75 – 80 (2014).
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Giani T, D’andrea MM et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58 (10 ), 5696 – 5703 (2014).
   PubMed Web of Science ®Google Scholar
• Bonura C, Giuffre M, Aleo A et al. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones. PLoS ONE 10 (7 ), e0132936 (2014).
   Web of Science ®Google Scholar
• Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48 (1 ), 15 – 22 (2004).
   PubMed Web of Science ®Google Scholar
• Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Huang TD, Nordmann P. Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium. Antimicrob. Agents Chemother. 52 (9 ), 3463 – 3464 (2008).
   PubMed Web of Science ®Google Scholar
• Voulgari E, Zarkotou O, Ranellou K et al. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J. Antimicrob. Chemother. 68 (1 ), 84 – 88 (2013).
   PubMed Web of Science ®Google Scholar
• Villa J, Viedma E, Branas P, Mingorance J, Chaves F. Draft whole-genome sequence of OXA-48-producing multidrug-resistant Klebsiella pneumoniae KP_ST11_OXA-48. Genome Announc 2 (4 ), e00737-14 (2014).
   PubMedGoogle Scholar
• Tsakris A, Poulou A, Bogaerts P, Dimitroulia E, Pournaras S, Glupczynski Y. Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates. J. Clin. Microbiol. 53 (4 ), 1245 – 1251 (2015).
   PubMed Web of Science ®Google Scholar
• Pereira PS, Borghi M, De Araujo CF et al. Clonal dissemination of OXA-370-producing Klebsiella pneumoniae in Rio de Janeiro, Brazil. Antimicrob. Agents Chemother. 59 (8 ), 4453 – 4456 (2015).
   PubMed Web of Science ®Google Scholar
• Shi W, Li K, Ji Y et al. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 beta-lactamase production. Braz. J. Microbiol. 44 (2 ), 435 – 442 (2013).
   PubMed Web of Science ®Google Scholar
• Llobet E, March C, Gimenez P, Bengoechea JA. Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob. Agents Chemother. 53 (1 ), 298 – 302 (2009).
   PubMed Web of Science ®Google Scholar
• Hernandez-Alles S, Conejo M, Pascual A, Tomas JM, Benedi VJ, Martinez-Martinez L. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J. Antimicrob. Chemother. 46 (2 ), 273 – 277 (2000).
   PubMed Web of Science ®Google Scholar
• Domenech-Sanchez A, Martinez-Martinez L, Hernandez-Alles S et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob. Agents Chemother. 47 (10 ), 3332 – 3335 (2003).
   PubMed Web of Science ®Google Scholar
• Partridge SR, Ginn AN, Wiklendt AM et al. Emergence of blaKPC carbapenemase genes in Australia. Int. J. Antimicrob. Agents 45 (2 ), 130 – 136 (2015).
   PubMed Web of Science ®Google Scholar
• Tang HJ, Ku YH, Lee MF, Chuang YC, Yu WL. In vitro activity of imipenem and colistin against a carbapenem-resistant Klebsiella pneumoniae isolate coproducing SHV-31, CMY-2, and DHA-1. Biomed. Res. Int. 2015, 568079 (2015).
   PubMed Web of Science ®Google Scholar
• Loli A, Tzouvelekis LS, Tzelepi E et al. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1. J. Antimicrob. Chemother. 58 (3 ), 669 – 672 (2006).
   PubMed Web of Science ®Google Scholar
• Poulou A, Voulgari E, Vrioni G et al. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J. Clin. Microbiol. 51 (10 ), 3176 – 3182 (2013).
   PubMed Web of Science ®Google Scholar
• Domenech-Sanchez A, Hernandez-Alles S, Martinez-Martinez L, Benedi VJ, Alberti S. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J. Bacteriol. 181 (9 ), 2726 – 2732 (1999).
   PubMed Web of Science ®Google Scholar
• Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob. Agents Chemother. 50 (10 ), 3396 – 3406 (2006).
   PubMed Web of Science ®Google Scholar
• Ogawa W, Li DW, Yu P et al. Multidrug resistance in Klebsiella pneumoniae MGH78578 and cloning of genes responsible for the resistance. Biol. Pharm. Bull. 28 (8 ), 1505 – 1508 (2005).
   PubMed Web of Science ®Google Scholar
• Abuzaid A, Hamouda A, Amyes SG. Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacDeltaE and qacE efflux pump genes and antibiotic resistance. J. Hosp. Infect. 81 (2 ), 87 – 91 (2012).
   PubMed Web of Science ®Google Scholar
• Pages JM, Lavigne JP, Leflon-Guibout V et al. Efflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS ONE 4 (3 ), e4817 (2009).
   PubMed Web of Science ®Google Scholar
• Ogawa W, Onishi M, Ni R, Tsuchiya T, Kuroda T. Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae. Gene 498 (2 ), 177 – 182 (2012).
   PubMed Web of Science ®Google Scholar
• Srinivasan VB, Singh BB, Priyadarshi N, Chauhan NK, Rajamohan G. Role of novel multidrug efflux pump involved in drug resistance in Klebsiella pneumoniae. PLoS ONE 9 (5 ), e96288 (2014).
   PubMed Web of Science ®Google Scholar
• Kayama S, Koba Y, Shigemoto N et al. Imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae producing OXA-181 in Japan. Antimicrob. Agents Chemother. 59 (2 ), 1379 – 1380 (2015).
   PubMed Web of Science ®Google Scholar
• Jeong SH, Lee KM, Lee J et al. Clonal and horizontal spread of the blaOXA-232 gene among Enterobacteriaceae in a Korean hospital. Diagn. Microbiol. Infect. Dis. 82 (1 ), 70 – 72 (2015).
   PubMed Web of Science ®Google Scholar
• Novais A, Rodrigues C, Branquinho R et al. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones. Eur. J. Clin. Microbiol. Infect. Dis 31 (11 ), 3057 – 3063 (2012).
   PubMed Web of Science ®Google Scholar
• Tsai YK, Liou CH, Fung CP, Lin JC, Siu LK. Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems. PLoS ONE 8 (11 ), e79640 (2013).
   PubMed Web of Science ®Google Scholar